CSIMarket
 


Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

LH's Income from Cont. Operations Growth by Quarter and Year

Laboratory Of America Holdings's Income from Cont. Operations results by quarter and year




LH Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 553.60 938.60 227.30
III Quarter September 353.20 587.80 703.70 221.00
II Quarter June 358.90 468.00 231.60 190.70
I Quarter March 492.10 770.10 -316.90 185.90
FY   1,204.20 2,379.50 1,557.00 824.90



LH Income from Cont. Operations third quarter 2022 Y/Y Growth Comment
Laboratory Corporation Of America Holdings reported fall in Income from Cont. Operations in the third quarter 2022 by -39.91% to $ 353.20 millions, from the same quarter in 2021.
The drop in the third quarter 2022 Laboratory Corporation Of America Holdings's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations doubling of 253.01%.

Looking into third quarter 2022 results within Medical Laboratories industry 7 other companies have achieved higher Income from Cont. Operations growth. While Laboratory Corporation Of America Holdings' s Income from Cont. Operations drop of -39.91% ranks overall at the positon no. 1659 in the third quarter 2022.




LH Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -41.02 % 312.93 % 43.59 %
III Quarter September -39.91 % -16.47 % 218.42 % -30.72 %
II Quarter June -23.31 % 102.07 % 21.45 % -18.54 %
I Quarter March -36.1 % - - 7.77 %
FY   - 52.83 % 88.75 % -6.67 %

Financial Statements
Laboratory Of America Holdings's third quarter 2022 Income from Cont. Operations $ 353.20 millions LH's Income Statement
Laboratory Of America Holdings's third quarter 2021 Income from Cont. Operations $ 587.80 millions Quarterly LH's Income Statement
New: More LH's historic Income from Cont. Operations Growth >>


LH Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -5.82 % 33.38 % 2.85 %
III Quarter September -1.59 % 25.6 % 203.84 % 15.89 %
II Quarter June -27.07 % -39.23 % - 2.58 %
I Quarter March -11.11 % -17.95 % - 17.44 %
FY (Year on Year)   - 52.83 % 88.75 % -6.67 %




Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #105
Overall #1659

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
15950 % 253.01 % -99.12 %
(Mar 31 2016)   (Mar 31 2015)
Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #105
Overall #1659
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
15950 % 253.01 % -99.12 %
(Mar 31 2016)   (Mar 31 2015)

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Laboratory Of America Holdings's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
16770 % 253.18 % -99.16 %
(Jun 30 2015)  


LH's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2022 Laboratory Corporation Of America Holdings reported decrease in Income from Cont. Operations sequentially by -1.59% to $ 353.20 millions, from $ 358.90 millions achived in the previous reporting period.

Some seasonal factors could not recover the III. Quarter for the Laboratory Corporation Of America Holdings, Alyssa Moore, market observer from Birmingham said, she identified additional difficulties down the road for the Medical Laboratories's company and mentioned that average sequential Income from Cont. Operations growth is at 253.18% for the Medical Laboratories's company.

Within Medical Laboratories industry 3 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Laboratory Of America Holdings's Income from Cont. Operations growth quarter on quarter, overall rank is 483.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #4
Healthcare Sector #42
Overall #483
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #4
Healthcare Sector #42
Overall #483
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
16770 % 253.18 % -99.16 %
(Jun 30 2015)  


LH's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2022 Laboratory Corporation Of America Holdings realized decrease in Income from Cont. Operations from the previous quarter by -1.59% to $ 353.20 millions, from $ 358.90 millions achived a quarter before.

Even seasonal influence that usually elevate III. Quarter 2022 performance, could not recover the III. Quarter for the Laboratory Corporation Of America Holdings, Alyssa Moore, market observer from Birmingham said, she mentioned little caution towards Laboratory Of America Holdings's outlook, she identified further challenges down the road for the Medical Laboratories's company.

Within Medical Laboratories industry 3 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Laboratory Of America Holdings's Income from Cont. Operations growth quarter on quarter, overall rank is 483.


Laboratory Of America Holdings's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ 1,757.80 $ 1,992.40 $ 2,101.50 $ 2,379.50 $ 2,764.50
Y / Y Income from Cont. Operations Growth (TTM) -36.42 % -30.83 % -20.52 % 52.83 % 226.89 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 754 # 433 # 439 # 729 # 246
Seqeuential Income from Cont. Operations Change (TTM) -11.77 % -5.19 % -11.68 % -13.93 % -4.02 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 803 # 391 # 486 # 1689 # 1852




Cumulative Income from Cont. Operations growth Comment
Laboratory Of America Holdings's cumulative 12 months Income from Cont. Operations continue to drop, but on the faster rate at -36.42% year on year, at Sep 30 2022 compare to the -30.83% decrease at Jun 30 2022. If the Laboratory Of America Holdings's fiscal year would end at Sep 30 2022, annual Income from Cont. Operations would be $1,758 millions.

In the Healthcare sector 55 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 433 to 754.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
132.98 %
3.7 %
-60.95 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 6
Healthcare Sector # 56
Overall # 754

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
720.86 %
30.37 %
-64.1 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 64
S&P 500 # 803
Cumulative Income from Cont. Operations growth Comment
Laboratory Of America Holdings's cumulative 12 months Income from Cont. Operations continue to drop, but on the faster rate at -36.42% year on year, at Sep 30 2022 compare to the -30.83% decrease at Jun 30 2022. If the Laboratory Of America Holdings's fiscal year would end at Sep 30 2022, annual Income from Cont. Operations would be $1,758 millions.

In the Healthcare sector 55 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 433 to 754.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
132.98 %
3.7 %
-60.95 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 6
Healthcare Sector # 56
Overall # 754

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
720.86 %
30.37 %
-64.1 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 64
S&P 500 # 803




Other Income from Cont. Operations Growth
Medical Laboratories Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
LH's Income from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for LH's Competitors
Income from Cont. Operations Growth for Laboratory Of America Holdings's Suppliers
Income from Cont. Operations Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar Income from Cont. Operations drop for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2022
Addus Homecare Corporation-0.29%$ -0.294 millions
Royalty Pharma Plc-0.62%$ -0.623 millions
Zoetis Inc -4.35%$ -4.348 millions
Henry Schein Inc -4.41%$ -4.410 millions
Charles River Laboratories International inc -7.18%$ -7.177 millions
Sotera Health Company-8.58%$ -8.577 millions
U S Physical Therapy Inc-9.22%$ -9.219 millions
Pediatrix Medical Group Inc -9.52%$ -9.523 millions
Ironwood Pharmaceuticals inc -9.90%$ -9.899 millions
Te Connectivity ltd -10.83%$ -10.831 millions
Semler Scientific inc -11.45%$ -11.446 millions
National Research Corporation-14.07%$ -14.073 millions
Lemaitre Vascular Inc-16.11%$ -16.113 millions
Intuitive Surgical Inc -16.14%$ -16.142 millions
Molecular Templates Inc -18.92%$ -18.919 millions
Regeneron Pharmaceuticals Inc -19.39%$ -19.391 millions
Universal Health Services Inc -19.40%$ -19.402 millions
Zynex inc -20.21%$ -20.206 millions
Progyny Inc -21.34%$ -21.344 millions
Khosla Ventures Acquisition Co -22.51%$ -22.507 millions
Tenax Therapeutics Inc -23.22%$ -23.222 millions
Maravai Lifesciences Holdings Inc -24.97%$ -24.966 millions
Reynolds Consumer Products Inc -27.27%$ -27.273 millions
Taitron Components Incorporated-28.61%$ -28.614 millions
Merck and Co Inc -28.83%$ -28.834 millions
Organon and Co -29.72%$ -29.721 millions
Gilead Sciences Inc -30.94%$ -30.936 millions
West Pharmaceutical Services Inc -31.32%$ -31.321 millions
Abbott Laboratories-31.67%$ -31.667 millions
Surgery Partners Inc -31.71%$ -31.707 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HSTC's Profile

Stock Price

HSTC's Financials

Business Description

Fundamentals

Charts & Quotes

HSTC's News

Suppliers

HSTC's Competitors

Customers & Markets

Economic Indicators

HSTC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071